Akron, Ohio

Altasciences Appoints New General Manager, Clinical Operations

Retrieved on: 
Monday, January 29, 2024

Altasciences announced the appointment of James Brazeal as General Manager, Clinical Operations, at its clinical facility in Kansas City.

Key Points: 
  • Altasciences announced the appointment of James Brazeal as General Manager, Clinical Operations, at its clinical facility in Kansas City.
  • James joins Altasciences having previously worked as Vice President of Research at Akron Children’s Hospital, and most recently as Vice President of Research Operations for Circuit Clinical.
  • “James’ proven leadership skills, and deep knowledge of all phases of clinical research, will be invaluable in delivering expert guidance for our clients along their early-phase clinical journey,” said Ingrid Holmes, Vice President, Clinical Operations, Altasciences.
  • With close to a decade of experience in the healthcare and pharmaceutical sectors, including clinical pharmacology, James will apply his knowledge to oversee the day-to-day management of clinical operations at Altasciences’ 140-bed, Phase I, clinical pharmacology unit in Kansas City.

Ohio Virtual Academy Student Wins Imagination Creation Contest, Artwork Helps Raise Over $165K for Akron Children’s Hospital

Retrieved on: 
Tuesday, October 3, 2023

Moore’s artwork was built into a real-life playhouse that was auctioned off, raising over $165,000 for the Akron Children’s Hospital .

Key Points: 
  • Moore’s artwork was built into a real-life playhouse that was auctioned off, raising over $165,000 for the Akron Children’s Hospital .
  • View the full release here: https://www.businesswire.com/news/home/20231003579659/en/
    OHVA student Dakota Moore's playhouse design on display at Eastwood Mall in Niles, OH.
  • “I was inspired to draw an igloo because I wanted to incorporate my favorite animals — penguins, polar bears, and walruses.
  • Bidding for Moore’s igloo playhouse started at $5,500 and, alongside the other playhouses, helped raise over $165,000 which was donated to the Akron Children’s Hospital.

Akron Bio Appoints Christopher Murphy as Chief Executive Officer

Retrieved on: 
Monday, December 12, 2022

Akron Bio (Akron), a provider of critical inputs for cell and gene therapies, today announced the appointment of Christopher Murphy as Chief Executive Officer.

Key Points: 
  • Akron Bio (Akron), a provider of critical inputs for cell and gene therapies, today announced the appointment of Christopher Murphy as Chief Executive Officer.
  • Mr. Murphy is a biotechnology industry veteran with more than 30 years of experience in advanced therapy and biological drug development and manufacturing.
  • Mr. Murphy joined Thermo Fisher Scientific as part of its acquisition of Brammer Bio, where he served as Chief Operations Officer.
  • Mr. Murphy said, I am incredibly excited to join Akron Bio and partner with innovators to provide high-quality, critical materials and services that power the future of medicine.

Testing Confirms Fentanyl-Heroin Resistant Glove

Retrieved on: 
Tuesday, May 31, 2022

MINERVA, Ohio, May 31, 2022 /PRNewswire/ -- P H & S Products, LLC has been awarded by the FDA a 510(k) medical device Class I listing for a two-tone single-use only, examination grade glove for protection against fentanyl, heroin, and gastric acid per the ASTM D6978-05 standard. Using these 510(k) numbers, the FDA regulates and certifies the safety of these products to provide a barrier for the bare hand encountering these opioids alone or a mixture of all three substances.

Key Points: 
  • Ohio Glove Company Announces FDA 510(k) Medical Approval for Get-A-Grip and Intercept Free Nitrile Glove for First Responder Personal Protection.
  • PH&S Products awarded by the FDA a 510(k) medical device Class 1 listing for protection against fentanyl, heroin.
  • The 510(k) certifications were awarded to both the Get-A-Grip two tone powder free, nitrile glove with a diamond grip pattern and the Intercept Free powder free nitrile NFPA (National Fire Protective Agency) approved two tone, accelerator free glove.
  • ARDL testing showed the fentanyl, heroin and gastric acid did not permeate the gloves up to 240 minutes of exposure.

AtNetPlus is Making Waves – A Technology Company with a Lot of Heart

Retrieved on: 
Thursday, May 5, 2022

STOW, Ohio, May 05, 2022 (GLOBE NEWSWIRE) -- AtNetPlus, an IT Managed Service Provider based out of Stow, Ohio, has been taking Northeast Ohio by storm.

Key Points: 
  • STOW, Ohio, May 05, 2022 (GLOBE NEWSWIRE) -- AtNetPlus, an IT Managed Service Provider based out of Stow, Ohio, has been taking Northeast Ohio by storm.
  • The company, which has been in business for over 23 years, has seen one of the biggest growth spurts in its history over the past year.
  • This success couldnt be achieved without AtNetPluss service employees who provide this award-winning service to its clients.
  • AtNetPlus is currently hiring for multiple positions:
    AtNetPlus is a Managed Service Provider that specializes in wrangling all things technology for small to mid-sized businesses.

TecTraum’s pro2cool® Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions

Retrieved on: 
Wednesday, November 3, 2021

TecTraum Inc. , dedicated to providing the worlds first point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool, as a Breakthrough Device.

Key Points: 
  • TecTraum Inc. , dedicated to providing the worlds first point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool, as a Breakthrough Device.
  • The device provides localized cooling for the head and neck to lower blood temperature before it enters the brain.
  • Researchers have observed significant improvements in clinical outcomes through the cooling of the brain within days of the concussion.
  • With the pro2cool System receiving FDA designation as a Breakthrough Device, TecTraum is strongly positioned for revolutionizing the treatment of concussions and providing an essential medical device for young athletes.

ClubCorp and University of Utah Partner to Develop Premier Stadium Club

Retrieved on: 
Thursday, July 29, 2021

The club will be a year-round private club at Rice-Eccles Stadium opening in the fall of 2021.

Key Points: 
  • The club will be a year-round private club at Rice-Eccles Stadium opening in the fall of 2021.
  • Offering stunning stadium and mountain views as well as expansive outdoor patios, the Club will be located in the Ken Garff Red Zone in the south end zone.
  • The U Club will be managed by ClubCorps dynamic, rapidly growing stadium division and is the eighth stadium property in the division.
  • ClubCorp properties include: Firestone Country Club (Akron, Ohio); Mission Hills Country Club (Rancho Mirage, California); The Woodlands Country Club (The Woodlands, Texas); and The Metropolitan in Chicago.

Babcock & Wilcox Enterprises to Present at Jefferies Industrials Conference on August 3, 2021

Retrieved on: 
Tuesday, July 27, 2021

Babcock & Wilcox Enterprises, Inc. ("B&W") (NYSE: BW) has been invited to present at Jefferies Industrials Conference, which is being held virtually on August 3-4, 2021.

Key Points: 
  • Babcock & Wilcox Enterprises, Inc. ("B&W") (NYSE: BW) has been invited to present at Jefferies Industrials Conference, which is being held virtually on August 3-4, 2021.
  • Kenneth Young, B&Ws Chairman and Chief Executive Officer, and Louis Salamone, B&Ws Chief Financial Officer, are scheduled to present on August 3, 2021 at 3:30 p.m. Eastern time.
  • Jefferies Industrials Conference is a virtual event that will feature presentations, fireside chats & 1x1 meetings with around 200 public and private industrial companies.
  • Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises is a leader in energy and environmental products and services for power and industrial markets worldwide.

Goodyear To Announce Second Quarter 2021 Financial Results

Retrieved on: 
Friday, July 23, 2021

AKRON, Ohio, July 23, 2021 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) will report second quarter 2021 financial results on Friday, Aug. 6,to be followed by an investor conference call at 9:30 a.m. EDT.

Key Points: 
  • AKRON, Ohio, July 23, 2021 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) will report second quarter 2021 financial results on Friday, Aug. 6,to be followed by an investor conference call at 9:30 a.m. EDT.
  • Prior to the commencement of the call, the company will post the financial and other related information that will be presented on its investor relations website: http://investor.goodyear.com .
  • (800) 895-3361 or (785) 424-1062 before 9:25 a.m.and providing the conference ID "Goodyear."
  • The company strives to develop state-of-the-art products and services that set the technology and performance standard for the industry.

FirstEnergy to Webcast Second Quarter Earnings Teleconference

Retrieved on: 
Friday, July 16, 2021

AKRON, Ohio, July 16, 2021 /PRNewswire/ --FirstEnergy Corp. (NYSE: FE) will release financial results for the second quarter and first half of 2021 after markets close on Thursday, July 22.

Key Points: 
  • AKRON, Ohio, July 16, 2021 /PRNewswire/ --FirstEnergy Corp. (NYSE: FE) will release financial results for the second quarter and first half of 2021 after markets close on Thursday, July 22.
  • These results will be discussed by FirstEnergy management during a conference call with financial analysts at 10 a.m. EDT on Friday, July 23.
  • The webcast and presentation will be available for replay on the site for up to one year.
  • The company plans to post its second quarter presentation and supporting materials to the investor section of the website after markets close on July 22.